Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content Volume 11 Issue 2 - August 2019



Relationship between gamma glutamyl transferase (GGT) and psychiatric comorbidity among alcohol dependent in-patients: A cross-sectional study

 

R Jaisingh1, S R Nirmal2*

 

1Assistant Professor, 2Associate Professor, Department of Psychiatry, DSMCH, Perambalur, INDIA.

Email: drsrnirmal@gmail.com

 

Abstract               Aim: To examine the prevalence and pattern of psychiatric disorders in alcohol dependence (ADS) and their relationship with physical and laboratory findings. Materials and Methods: Hundred males admitted in a tertiary care medical college with ADS were examined using International Classification of Disease-10th Edition, Alcohol Use Disorder Identification Test for alcohol use, blood sampling electrocardiogram, and ultrasonogram of abdomen. Results: Eighty percent had a comorbid Axis I or an Axis II psychiatric disorder, over 75% had nicotine dependence, and 50% had comorbid Axis II disorder, antisocial personality being the most common. Gamma glutamyl transferase (GGT) levels were raised and were significantly associated with comorbidity. Conclusions: High comorbidity of Axis I psychiatric disorders was found among persons with alcohol dependence. Axis II disorders were also present. GGT levels were elevated in most of patients and there was a significant association with psychiatric comorbidity.

Key Word: Alcohol dependence, physical correlates, psychiatric comorbidity, GGT

 

INTRODUCTION

Alcohol has been a major problem across the globe. Alcohol dependence is by far the most common substance use disorder among people across the world. The pattern of drinking varies from individual to individual. Somehow there is deliberate denial or falsification of dependence due to various reasons. Alcoholism is in the rise among Indians, and people seem to take to it at a younger age. The recent increase in consumption of alcohol, atleast in the state of Tamilnadu, can be attributed to Government availability of bars at almost all liquor sale outlets. People of rural origin who have sold out vast areas of their agricultural lands to real estate tycoons and industries are left with a lot of money and have no active occupation to do; they land up drinking alcohol and get dependent on it. ~ 50% of alcohol-dependent persons develop alcohol-induced clinical syndromes and are of particular importance to psychiatrists.1 Patients with comorbid psychiatric disorders constitute the majority of alcohol-dependent populations presenting to de-addiction clinics.2 Psychiatric comorbidity rates in alcohol-dependent persons range from 100% in psychiatric in-patient settings3 to 47% in community samples.4 In patients with dual diagnosis alcohol use and psychiatric illness become extensively intertwined over time and worsen outcomes of each other5 Hospitalized patients who are not truthful about their alcohol consumption may be at risk for an unplanned withdrawal. Self-reports of alcohol use such as CAGE and the Alcohol Use Disorders Identification Test (AUDIT) are valid, inexpensive, and non invasive, but patients easily can feign results6 Biochemical measures are more objective, and combinations of markers are an effective tool to detect recent heavy drinking in the 10% to 25% of patients who underreport alcohol use.7 Biochemical measures can detect acute alcohol intoxication and recent prolonged drinking. Because marker levels return to normal after long-term abstinence, ongoing monitoring can help detect a relapse before a patient admits to it.8 The aim of the present study was to examine physical and psychiatric comorbidity in association with alcohol dependence, and to analyze the relationship of physical and laboratory findings with psychiatric comorbidity at a rural based tertiary care teaching hospital psychiatry unit.

 

MATERIALS AND METHODS

The study was conducted at the Department of Psychiatry, Dhanalakshmi Srinivasan Medical College and Hospital, Perambalur, a tertiary care teaching hospital catering to the surrounding rural population from 2016 – 18. Consenting subjects fulfilling inclusion criteria was recruited into the study. Ethical approval was obtained from the Institutional Ethics Committee of Human Subjects. (To calculate sample size, the prevalence of psychiatric comorbidity in alcohol dependence was taken as 40%10 and error in precision was taken to be 30%. Using the formula, 2 √pq/n = prevalence × error/100, n was found to be 66.6. Thus, a minimum n = 67 was obtained. However eighty subjects were finally recruited.) Males diagnosed as alcohol dependence as per International Classification of Disease-10th Edition (ICD-10) Diagnostic Criteria for Research (World Health Organization, 1993) criteria,9 between ages 18 and 60 years, willing to participate, and to provide informed consent were requested for participation. Those with serious physical/neurological conditions or any other brain dysfunction interfering with assessment, with mental retardation or co-existing substance abuse or dependence other than for nicotine were excluded. They were recruited after obtaining valid written informed consent. All participants were assessed using a structured clinical interview to diagnose dependence, and Alcohol Use Disorder Identification Test (AUDIT) for alcohol use10. Blood sample, electrocardiogram (ECG) and ultrasonogram were done. Data analysis was conducted using the SPSS version 16.0 (San Francisco, CA). Chi-square test was used for any association between psychiatric comorbidity, ECG, and ultrasonogram changes. Student's t-test was used for comparing cases with or without comorbidity on continuous variables (age at presentation, age at onset, age at first intoxication, age at daily drinking, age at dependence, AUDIT score, and laboratory investigations). P <0.05 was accepted as cut-off for significance.

 

 RESULTS

Table 1: prevalence of psychiatric comorbidity

Psychiatric disorders - Comorbid

Prevalence %

Nicotne dependence

80

Personality disorders

Antisocial

Paranoid

Anxious avoidant

Anankastic

Schizoid

Histrionic

Emotionally unstable

Borderline

56

15

9

8

6

5

5

4

4

Anxiety disorders

Panic disorder

Generalized anxiety disorder

Phobic disorders

OCD

45

17

14

10

4

Affective disorders

Depression

Dysthymia

BPAD

Mania

29

15

9

2

3

Schizophrenia

3

Schizophrenia - like

4

Coplicated withdrawal (Seizures/ delirium)

12

A total of hundred participants (all males) were included with a mean age of 36.7 (standard deviation = 10.5), the large majority were educated upto high school only (0–8 years: 20%, >9 years: 50%, college education: 30%), married (75%), and resided in rural areas (65%), with nearly equal representation from nuclear (52%) or joint (48%) families. Nearly, one-fifth were unemployed and around 70% earned <Rs. 10,000/month. The lifetime prevalence of complicated alcohol withdrawal state was 12% and alcohol-induced psychotic disorder was 11%. The mean AUDIT score was 28.41 (8.03) with a wide range of 8–40 [Table 1]. Overall, 87% participants had a comorbid psychiatric disorder, the most common being nicotine dependence (80%). A total of 56 patients (56%) had comorbid personality disorders (PD) -antisocial (15%), paranoid (9%), and avoidant (8%). The least common were borderline (4%) and impulsive (4%). Lifetime prevalence among anxiety disorders was panic disorder (17%), generalized anxiety disorder (14%), phobic disorders (10%), and OCD (4%). Affective disorders were present in 29% of the participants and schizophrenia in 3%. There was no significant difference between those with or without comorbidity when age at presentation, age of attaining different alcohol milestones (age at first drink, first intoxication, daily drinking, and dependence), income, AUDIT scores, and lab markers (hemoglobin, mean corpuscular volume (MCV), fasting and postprandial blood sugar, bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, blood urea, serum creatinine, ultrasonogram, and ECG) were compared. Gamma glutamyl transferase (GGT) was the only marker (P < 0.023) that was shown to be significantly associated with psychiatric comorbidity. [Table 2]

 

Table 2: Clinical variables and psychiatric comorbidity

Clinical Variables

Comorbidity – Mean (SD)

t (p)

Present (n=87)

Absent (n=13)

AUDIT score

28.43 (7.95)

28.30 (9.02)

0.43 (0.967)

Liver function

Total Bilirubin

0.74 (0.33)

0.77 (0.24)

0.351(0.731)

AST

103.34 (92.14)

129.60 (99.05)

0.788 (0.447)

ALT

83.35 (68.51)

95.80 (64.67)

0.565 (0.583)

Alkaline Phosphatase

133.15 (55.89)

145.00 (60.80)

0.582 (0.572)

GGT

104.00 (52.09)

73.60 (32.83)

2.511 (0.023)

MCV (Hemogram)

92.91 (7.01)

92.97 (7.05)

0.023 (0.982)

AST - Aspartate aminotransferase; ALT – Alanine aminotransferase; GGT – Gamma

Glutamyl aminotransferase, MCV – Mean Corpuscular volume; SD – Standard Deviation

 

DISCUSSION

Our study found high rates of psychiatric disorders andPDs in a relatively stable Indian sample seeking inpatient deaddiction treatment. Only males were included as alcoholism is rare in females and few of them only seek treatment for alcohol or drug use. We did not find significant association between educational status and income with psychiatric comorbidity in contrast with other studies showing association with both higher and lower income and psychopathology.11,12,13 Psychiatric comorbidity and age at first drink, age at first intoxication, age at daily drinking, and age at dependence were not significantly correlated as opposed to many previous reports.11,12,13,14,15,16,17,18,19,20,21 Nicotine dependence expectedly topped the list of comorbidity, considering the prevalence, cheap, and easy availability of tobacco products in India.18 There were high rates of PDs, similar to studies by DeJong et al.21 (78% alcoholic inpatients with at least one Axis II disorder; 28% only one, and 50% more than one PD) and Morgenstern et al (58%).22 Lifetime prevalence for anxiety disorders was 45%, comparable to hospital-based studies by Schneider et al.16 and Bowen et al.23 with lifetime prevalence of anxiety disorders of 42% and 43.8%, respectively.19,23 The most common disorder was panic disorder (17% vs. 2–16%) in others12,24,25 followed by generalized anxiety disorder (14%), phobic disorders (10%) similar to Powell et al.,12 and obsessive compulsive disorders (4% vs. 2–12%) by others.2,9,16,17,20,25 Prevalence of lifetime diagnosis of affective disorders was 29%, the most common being depressive episode (15%) followed by dysthymia (9%), bipolar disorder (2%), mania (2%) and mania with psychotic symptoms (1%). Past hospital-based studies reported lifetime prevalence from 19% to 34%.2,9,26 Previous Indian studies reported a prevalence of 30%.25 The prevalence of schizophrenia was 3%, comparable with Hesselbrock et al.,24 Nurnberg et al.,29 2%, and Herz et al., 2.7%.20 Others reported rates ranging from 0.8% to 8.0%.4,9,16,17,20,25,26,27 The prevalence of alcohol-withdrawal seizures and delirium tremens was 7% and 4%, respectively, as compared to 3–5% and 5%, respectively, from the literature.28,29 The mean values of fasting blood sugar, postprandial blood sugar, ALT, AST, GGT, serum uric acid, and MCV were significantly higher, comparable to others.26,30,31,32 A statistically significant association was found between the psychiatric comorbidity and mean GGT value (P = 0.023) only. Significant changes were seen in ultrasonogram of 55%participants, but there was no association with psychiatric comorbidity. There was a significant association between GGT levels and AUDIT scores. However, no significant association between psychiatric comorbidity and AUDIT scores was found. Reasons for this finding are uncertain although limited sample size may be an issue. This study although a cross-sectional study focused on participants from an inpatient deaddiction of a tertiary care hospital catering to Perambalur and surrounding rural areas. It was conducted with sufficient sample size; structured interview schedules supplemented with clinical history were used. As we included male treatment seekers who were likely to be more ill, an inherent selection bias was unavoidable. Many subjects were not motivated and were brought to hospital unwillingly by relatives. Combinations of biomarkers improve the detection of physical comorbidity in alcohol-dependent persons.

 

REFERENCES

  1. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988;45:1023–31.[PubMed: 3263100
  2. Tyndel M. Psychiatric study of one thousand alcoholic patients. Can Psychiatr Assoc J. 1974; 19: 21–4. [PubMed: 4812974]
  3. McCabe D, Holmwood C. Comorbidity in general practice: The provision of care for people working with coexisting mental health problems and substance use by general practitioners. Common Wealth Department of Health and Ageing. 2003. [Last accessed on 2016 Apr 22]. Available from: http://www.health.gov.au/pubhlth/publicat/document/comorbid_gp.pdf .
  4. Channabasavanna SM, Ray R, Kaliaperumal VG. Patterns and problems of non alcoholic drug dependence in Karnataka. Bangalore: Dept. of Health and Family Welfare; 1986
  5. Driessen M, Veltrup C, Wetterling T, John U, Dilling H. Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcohol Clin Exp Res. 1998; 22: 77–86. 
  6. Allen JP, Anthenelli RM. Getting to the bottom of problem drinking: the case for routine screening. Current Psychiatry2003; 2(6):26-44.
  7. Killeen TK, Brady KT, Gold PB, et al. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend 2004; 73(2):141-7.
  8. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it. Prescrire Int 2007;16(87):24-31.
  9. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.
  10. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption – II. Addiction. 1993;88:791–804.
  11. Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR. Alcoholism and affective disorder: Clinical course of depressive symptoms. Am J Psychiatry. 1995;152:45–52. 
  12. Powell BJ, Penick EC, Nickel EJ, Liskow BI, Riesenmy KD, Campion SL, et al. Outcomes of co-morbid alcoholic men: A 1-year follow-up. Alcohol Clin Exp Res. 1992;16:131–8. 
  13. Schuckit MA, Tipp JE, Bucholz KK, Nurnberger JI, Jr, Hesselbrock VM, Crowe RR, et al. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction. 1997; 92: 1289–304. 
  14. Meyer RE. Prospects for a rational pharmacotherapy of alcoholism. J Clin Psychiatry. 1989; 50: 403–12.
  15. Herz LR, Volicer L, D'Angelo N, Gadish D. Additional psychiatric illness by diagnostic interview schedule in male alcoholics. Compr Psychiatry. 1990;31:72–9.
  16. Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, et al. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: The first multicentre study in Germany. Alcohol Alcohol. 2001; 36: 219–23.
  17. Manjunatha N, Saddichha S, Sinha BN, Khess CR, Isaac MK. Chronology of alcohol dependence: Implications in prevention. Indian J Community Med. 2008; 33: 233–7.
  18. GATS. Global Adult Tobacco Survey. New Delhi: Ministry of Health and Family Welfare; 2010.
  19. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry. 1985; 42: 1050–5. [PubMed: 4051682]
  20. Koivisto H, Hietala J, Anttila P, Parkkila S, Niemelä O. Long-term ethanol consumption and macrocytosis: Diagnostic and pathogenic implications. J Lab Clin Med. 2006; 147: 191–6. 
  21. DeJong CA, van den Brink W, Harteveld FM, van der Wielen EG. Personality disorders in alcoholics and drug addicts. Compr Psychiatry. 1993; 34: 87–94.
  22. Morgenstern J, Langenbucher J, Labouvie E, Miller KJ. The comorbidity of alcoholism and personality disorders in a clinical population: Prevalence rates and relation to alcohol typology variables. J Abnorm Psychol. 1997; 106: 74–84.
  23. Bowen RC, Cipywnyk D, D'Arcy C, Keegan D. Alcoholism, anxiety disorders, and agoraphobia. Alcohol Clin Exp Res. 1984; 8: 48–50. 
  24. Grant BF, Hasin DS, Dawson DA. The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: Examination of the primary-secondary distinction in a general population sample. J Affect Disord. 1996; 38: 113–28.
  25. Kisore P, Lal N, Trivedi JK, Dalal PK, Aga VM. A study of comorbidity in psychoactive substance dependence patients. Indian J Psychiatry. 1994;36:133–7.[PMCID: PMC2972480] 
  26. Nurnberg HG, Rifkin A, Doddi S. A systematic assessment of the comorbidity of DSM-III-R personality disorders in alcoholic outpatients. Compr Psychiatry. 1993; 34: 447–54.
  27. Kay J, Tasman A. Substance abuse: Alcohol use disorders. Essentials of Psychiatry. Hoboken: John Wiley and Sons Ltd\; 2006.
  28. Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia. A prospective community study. J Nerv Ment Dis. 1989; 177: 408–14. [PubMed: 2746194]
  29. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol. 1988; 49: 219–24.
  30. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, et al. Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry. 1996; 168: 612–9.
  31. Mundle G, Ackermann K, Mann K. Biological markers as indicators for relapse in alcohol-dependent patients. Addict Biol. 1999;4: 209–14.
  32. Litten RZ, Allen JP, Fertig JB. Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: Alternative measures of excessive alcohol consumption. Alcohol Clin Exp Res. 1995; 19: 1541–6.